NovAccess Global Inc. (OTCPK: XSNX)
Health Care · Biotechnology · US
$—
— today · — 1Y
NovAccess Global Inc. (OTCPK: XSNX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.33K and employs 2 people.
trading between 0.00 and 0.05.
Tweenvest scores NovAccess Global Inc. across four factors: quality 27/100, value 47/100. Its strongest factor is value.
XSNX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.33K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 98.77
- 52-week high
- $0.05
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 61.65M
- Employees
- 2
- Next earnings
- —
About NovAccess Global Inc.
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
- ISIN
- US67001N1072
- Founded
- 1997
- Listed since
- Sep 21, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bio-Path Holdings, Inc.OTCPK: BPTH | $15.09K | $0.00 | -40.00% |
| IO Biotech, Inc.OTCPK: IOBT.Q | $14.39K | $0.00 | +100.00% |
| Windtree Therapeutics, Inc.OTCPK: WINT | $13.50K | $0.00 | +50.00% |
| Vaxxinity, Inc.OTCPK: VAXX | $12.68K | $0.00 | -99.00% |
| Scorpius Holdings, Inc.OTCPK: SCPX | $12.23K | $0.00 | -60.00% |
| ObsEva SAOTCPK: OBSE.F | $11.72K | $0.00 | +9900.00% |
| MabCure, Inc.OTCPK: MBCI | $11.72K | $— | — |
| Trevena, Inc.OTCPK: TRVN | $11.51K | $0.01 | +7.14% |
Figures last refreshed Oct 4, 2026.